College Stock: Penny Stock News

After moving to the day’s high of $0.45, $IVOB closed up 8.3%. Honors Students learned about $IVOBwhen it was trading at only $0.10 and has since moved up 350%, proving that $IVOB is certainly Ivy League Stock Pick material.

The New York Times has been pretty interested in infertility and talking about IVF treatments lately and in another recent story on their website no less than 9 medical and scientific professionals discussed the downside to twins and other multiple birth pregnancies. This is why The Dean plans to teach the CollegeStock Community about the many reasons he believes things are truly coming together for $IVOB—The Dean’s Billion Dollar Baby.

Mark Evans, president of the Fetal Medicine Foundation of America and the director of Comprehensive Genetics in New York, believes one of the main problems with multiple birth pregnancies is the cost. Typically, twins naturally occur in 1 out of 90 births or 45,000 per year in the United States. But in 2006, more than 130,000 sets of twins were born which moves the natural 1.1% statistic to a whopping 65% chance that a woman pushing a stroller down a sidewalk would be the mother of twins who used a form of IVF to get pregnant.

Alongside the issues The Dean taught the CollegeStock Community about yesterday—miscarriage, prematurity, learning disorders and death of the mother—multiple birth pregnancies can also cause structural abnormalities of the brain, spine and heart and have a 10% to 15% risk of having twin-to-twin transfusion syndrome where the fetuses have to fight over the shared blood supply and both are negatively affected.

Mark Ivans also argues that, at this point in time, adopting a program for single embryo transfer in the United States won’t work because the price of IVF is too expensive—$15,000 or more. Due to this high cost, many infertile couples assume the risk of a multiple birth pregnancy by allowing the transfer of more than one embryo. This has led to an increase in the success rates of IVF treatments but it also increases the likelihood of twin births, pregnancy complications, and affectins the overall health of the babies and their mother. In addition, this comes with the additional cost of twice the amount of hospital bills and possible long-term healthcare costs of problems associated with multiple birth pregnancies.

Another featured expert in The New York Times report on multiple births is Helen Richens, who is the policy manager for multiple births at the Human Fertilization and Embryology Authority (HFEA). Richens reveals that 1 in 80 natural conceptions result in twins or triplets in the UK—that’s only 1.25%. But women in Britain who seek IVF treatments have a much higher chance of multiple births—as high as 20%.

Richens also discusses that her organization’s concerns and efforts are to prevent the “additional risks these mothers and babies face.” In fact, HFEA has developed the “One at a Time” campaign to establish professional guidelines for elective single embryo transfer. HFEA is not acting alone and plans to reduce IVF multiple births to 10% because some figures report rates as high as 24%.

The Dean believes that the more people educate themselves about IVF and the many concerns surrounding such treatments, the better the chances The Dean’s Billion Dollar Baby will be born.

The Dean thinks that $IVOB‘s recent news of a single baby being born using 1 embryo is only the beginning of something much, much larger for the company and the shareholders alike.